|

Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes

RECRUITINGN/ASponsored by University of Virginia
Actively Recruiting
PhaseN/A
SponsorUniversity of Virginia
Started2026-01-01
Est. completion2027-06-01
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted
Locations1 site

Summary

This study is examining whether short-term supplementation with inorganic nitrate, in the form of beetroot juice, can enhance blood vessel health, insulin sensitivity, and exercise capacity in individuals with prediabetes. We will be comparing the responses in individuals who are taking metformin to those who are naive to metformin. The results from this study may help identify non-pharmacological interventions in prediabetes.

Eligibility

Age: 18 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Individuals who can communicate meaningfully with the investigator and can provide written consent.
* Confirmed prediabetic individuals (ages 18-60 years old) (2-hour glucose of 140-199 mg/dL following OGTT test or HbA1c between 5.7-6.4% tested on two occasions within 6 months).
* Taking metformin (stable dose for at least a week) or naïve to metformin
* Sedentary (\<1 day/week of structured exercise)
* Be able to perform exercise on a cycle ergometer without assistance
* Stable medication regimen for the last 6 months
* If female, have a normal menstrual cycle

Exclusion Criteria:

* Estimated Glomerular filtration rate (GFR) ≤ 45
* Body mass index ≥ 40 Kg/m2
* HbA1c \> 6.4%
* Smokers within the last 5 years
* Has experienced significant weight loss \~3 kg in the last three months or is taking any weight loss drugs
* Current medical condition that prohibits exercising at high intensities
* Currently on hormone replacement of any kind
* History of myocardial infarction, cerebrovascular event, acute or unstable disease other than pre-diabetes or obesity
* Currently taking any of the following medications (calcium channel blockers, statins, ACE or renin inhibitors, angiotensin receptor blockers, organic nitrates (e.g., nitroglycerine) or recent regular use of inorganic nitrates, alpha- or beta-blockers, diuretics, proton pump inhibitors, PDE-5 inhibitors (e.g.,: Cialis, Viagra), or xanthine oxidase inhibitors (e.g.,: Allopurinol))
* Oral antibiotic use within the previous four weeks, including over-the-counter antibacterial mouthwash or a mouthwash containing chlorhexidine and unwilling to discontinue use
* Oral cancer/severe oral disease
* Uncontrolled hypertension (\>140/90)
* Had hysterectomy or oophorectomy
* Fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking participants

Conditions6

DiabetesFemalesMalesMetforminPreDiabetesSedentary

Locations1 site

University of Virginia
Charlottesville, Virginia, 22903

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.